BRPI1008561A2 - vacinas vivas atenuadas - Google Patents

vacinas vivas atenuadas

Info

Publication number
BRPI1008561A2
BRPI1008561A2 BRPI1008561A BRPI1008561A BRPI1008561A2 BR PI1008561 A2 BRPI1008561 A2 BR PI1008561A2 BR PI1008561 A BRPI1008561 A BR PI1008561A BR PI1008561 A BRPI1008561 A BR PI1008561A BR PI1008561 A2 BRPI1008561 A2 BR PI1008561A2
Authority
BR
Brazil
Prior art keywords
live attenuated
attenuated vaccines
vaccines
live
attenuated
Prior art date
Application number
BRPI1008561A
Other languages
English (en)
Inventor
Tseng Chi-Wen
Francis Browning Glenn
Francis Markham Phillip
Original Assignee
Australian Poultry Crc Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2009900736A external-priority patent/AU2009900736A0/en
Application filed by Australian Poultry Crc Pty Ltd filed Critical Australian Poultry Crc Pty Ltd
Publication of BRPI1008561A2 publication Critical patent/BRPI1008561A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/30—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycoplasmatales, e.g. Pleuropneumonia-like organisms [PPLO]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
BRPI1008561A 2009-02-20 2010-02-17 vacinas vivas atenuadas BRPI1008561A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2009900736A AU2009900736A0 (en) 2009-02-20 Live attenuated vaccines
PCT/AU2010/000172 WO2010094064A1 (en) 2009-02-20 2010-02-17 Live attenuated vaccines

Publications (1)

Publication Number Publication Date
BRPI1008561A2 true BRPI1008561A2 (pt) 2018-07-24

Family

ID=42633348

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1008561A BRPI1008561A2 (pt) 2009-02-20 2010-02-17 vacinas vivas atenuadas

Country Status (10)

Country Link
US (1) US20120045475A1 (pt)
EP (1) EP2398892A4 (pt)
JP (1) JP5753098B2 (pt)
CN (1) CN102317439B (pt)
AU (1) AU2010215065B2 (pt)
BR (1) BRPI1008561A2 (pt)
CA (1) CA2750136A1 (pt)
MX (1) MX2011007606A (pt)
RU (1) RU2556813C2 (pt)
WO (1) WO2010094064A1 (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2337846T (pt) 2008-09-26 2018-04-05 Ambrx Inc Vacinas e microrganismos dependentes da replicação de aminoácidos não naturais
KR20130086154A (ko) 2010-05-19 2013-07-31 바이오프로퍼티스 피티와이 엘티디 약독화된 미코플라스마와 관련된 방법
WO2013091040A2 (pt) * 2011-12-22 2013-06-27 Universidade Federal De Minas Gerais - Ufmg Cepa atenuada de brucella ovis, composição vacinal e uso
US8734814B2 (en) 2012-03-02 2014-05-27 Asis Datta Recombinant microorganisms and uses thereof
JP6262728B2 (ja) * 2012-06-27 2018-01-17 メリアル リミテッド 弱毒化ストレプトコッカス・スイスワクチン並びにその製造方法及び使用
US11389518B2 (en) * 2015-08-14 2022-07-19 Zoetis Services Llc Mycoplasma bovis compositions
US10071149B2 (en) 2016-05-03 2018-09-11 Brigham Young University Temperature sensitive multivalent Bordetella avium vaccines
CN105999281B (zh) * 2016-07-26 2019-02-19 河南后羿生物工程股份有限公司 禽类活病毒用冻干保护剂、制备方法及应用
US20180168196A1 (en) 2016-12-15 2018-06-21 Nestec Sa Compositions and methods that modulate bacteria in a companion animal
MA47383A (fr) 2017-01-27 2019-12-04 Univ Florida Vaccin de sécurité alimentaire pour lutter contre salmonella enterica et réduire campylobacter chez la volaille
CN107308445B (zh) * 2017-07-26 2020-11-24 山东省滨州畜牧兽医研究院 羊三联四防亚单位疫苗及其制备方法
CA3070102A1 (en) * 2017-07-31 2019-02-07 Kansas State University Research Foundation Vaccines against tick-borne diseases
CN108414751A (zh) * 2018-03-22 2018-08-17 山西省动物疫病预防控制中心 一种鸡白痢染色凝集抗原及其制备方法
CN108929864B (zh) * 2018-07-19 2021-03-23 浙江农林大学 用于预防鸡传染性法氏囊病的致弱病毒及用途
CN109758427B (zh) * 2019-02-26 2021-11-02 兆丰华生物科技(福州)有限公司 一种伪狂犬病活疫苗耐热保护剂及其制备方法和应用
WO2023032950A1 (ja) * 2021-08-30 2023-03-09 天野エンザイム株式会社 向上したタンパク質生産性を有する微生物及びその利用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4000256A (en) * 1975-04-30 1976-12-28 Merck & Co., Inc. Varicella vaccine and process for its preparation
US20040116661A1 (en) * 2000-10-26 2004-06-17 Holden David William Streptococcal genes
WO2002034773A2 (en) * 2000-10-26 2002-05-02 Imperial College Innovations Ltd. Streptococcal genes
GB0308691D0 (en) * 2003-04-07 2003-05-21 Xenova Res Ltd Vaccine preparations
WO2006089121A2 (en) * 2005-02-18 2006-08-24 Kent Seatech Corporation Streptococcus iniae phosphoglucomutase is a virulence factor and target for vaccine development
RU2468083C1 (ru) * 2011-04-25 2012-11-27 Закрытое акционерное общество "Научно-исследовательский институт Аджиномото-Генетика" (ЗАО "АГРИ") Способ получения l-аминокислоты с использованием бактерии семейства enterobacteriaceae, в которой ослаблена экспрессия генов, кодирующих транспортер лизина/аргинина/орнитина

Also Published As

Publication number Publication date
RU2011138410A (ru) 2013-03-27
EP2398892A1 (en) 2011-12-28
JP2012518388A (ja) 2012-08-16
AU2010215065B2 (en) 2014-05-15
JP5753098B2 (ja) 2015-07-22
RU2556813C2 (ru) 2015-07-20
AU2010215065A1 (en) 2011-08-11
CN102317439A (zh) 2012-01-11
MX2011007606A (es) 2011-08-08
WO2010094064A1 (en) 2010-08-26
CA2750136A1 (en) 2010-08-26
US20120045475A1 (en) 2012-02-23
EP2398892A4 (en) 2013-03-06
CN102317439B (zh) 2015-11-25

Similar Documents

Publication Publication Date Title
BRPI1008561A2 (pt) vacinas vivas atenuadas
DK3170508T3 (da) Vaccineformuleringer
FR21C1022I2 (fr) Parvovirus vivants atténués
DK3033945T3 (da) Slagteanlæg
DK2394882T3 (da) Funktionssikret scanner
BRPI0816686A2 (pt) Cepas de micoplasma atenuadas vivas
FR2952291B3 (fr) Grill
BRPI0921578A2 (pt) vacinas unitemporais
DK2279652T3 (da) Kultivator
FI20095782A0 (fi) Tulipesä
BRPI1009979A2 (pt) aveso
BRPI0919102A2 (pt) vacinas de salmonella não-tifóide
DE202009012799U8 (de) Bettdecke
FI20105027A0 (fi) Höyrykattila
FR2949540B3 (fr) Cheminee
FR2955787B1 (fr) Autoclave torique
DE102010002918A8 (de) Briefkastenanlage
ZA200808034B (en) Live attenuated salmonella vaccine
ZA200808033B (en) Live attenuated salmonella vaccine
AU2009900736A0 (en) Live attenuated vaccines
TH129806B (th) วัคซีนพิษแบคทีเรีย
TH113563B (th) หม้อไอน้ำ
TH111586B (th) คอคซิดิโอสิส วัคซีน
TH106621B (th) การรักษาสำหรับ nafld
UA22416S (uk) Камін

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2482 DE 31-07-2018 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.